The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
PTC Therapeutics, Inc(NASDAQ:PTCT) 
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for the treatment of rare disorders. The company offers Translarna (ataluren) and Emflaza (deflazacort) for the treatment of nonsense mutation Duchenne muscular dystrophy in...
Website: http://www.ptcbio.com
Founded: 1998
Full Time Employees: 754
Sector: Healthcare
Industry: Biotechnology
PTC Therapeutics Days Payable Outstanding ttm (DPO)
PTC Therapeutics Days Receivable Outstanding ttm (DSO)
PTC Therapeutics Days Inventory Outstanding ttm (DIO)
PTC Therapeutics Op Cashflow Per Share ttm
PTC Therapeutics Free Cashflow Per Share ttm
PTC Therapeutics Cash Per Share ttm
PTC Therapeutics P/S ratio ttm
PTC Therapeutics (GAAP) P/E ratio ttm
PTC Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.